Teladoc Health, Inc. (0LDR.L) LSE

7.23

-0.33(-4.37%)

Updated at December 24 05:31PM

Currency In USD

Valuation

Market Cap1.55B
Enterprise Value1.84B
P/E Ratio-5.7
PEG Ratio0.85
Price/Sales Ratio0.51
Price/Book Ratio0.91
Enterprise/Revenue0.63
Enterprise/EBITDA-53.63

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.09
Operating Margin-0.11

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.16

Income Statement

Revenue2.57B
Revenue/Share14.39
Gross Profit1.82B
EBITDA31.72M
Net Income-1B
Diluted EPS-5.87

Balance Sheet

Total Cash726.25M
Total Cash/Share4.13
Total Debt1.04B
Total Debt/Equity0.74
Current Ratio2.7
Book Value Per Share7.92

Price History

52-Week Change-22.84
52-Week High30.38
52-Week Low7.11
Moving Average 50 Days18.78
Moving Average 200 Days20.8

Statistics

Average Volume19,437
Shares Outstanding174.95M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A